Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cosmax BTI, Inc. (044820.KS)
Seongnam-si, KR
Cosmax BTI, Inc., established in 1992 and headquartered in Seongnam, South Korea, specializes in the development, manufacturing, and distribution of a diverse array of items. These include cosmetic products, dietary supplements, pharmaceutical goods, and specialized packaging and machinery, primarily serving customers within South Korea. The company's comprehensive product lineup features sunscreens and foundation creams; various makeup creams and bases; hair and cleansing solutions; mascaras and nail care items; a broad spectrum of color cosmetics and skin tone formulations; lipsticks and eyeshadows; liquid lip essences; body care products and sheet masks; powder compacts and makeup pencils; and fragrances. Beyond its domestic operations, Cosmax BTI, Inc. also exports its merchandise to approximately 30 countries globally.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.19% | -9.68% | +15.51% | +48.20% | +53.85% | +51.19% | +63.30% | +138.37% | +15.07% | -64.94% | +856.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+8.0% ★ Q1'26: +33.0% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+77.5% ★ Q1'26: +2,062.7% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-1.3% Q1'26: -4.7% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+4.2% Q1'26: +8.0% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+2.9% Q1'26: +6.8% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.5% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×9.44× Q1'26: 5.55× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
199.87B
est: 406.62B (-50.8%)
|
266.92B
est: 216.50B (+23.3%)
|
298.29B
est: 904.00B (-67.0%)
|
438.28B
est: 1.18T (-62.8%)
|
525.90B
est: 473.00B (+11.2%)
|
576.00B
est: 2.32B (+24,695.8%)
|
597.63B
est: 406.62B (+47.0%)
|
645.21B
est: 216.50B (+198.0%)
|
904.00B
904.00B – 904.00B
+317.6% YoY
|
1.18T
1.18T – 1.18T
+30.2% YoY
|
473.00B
473.00B – 473.00B
-59.8% YoY
|
| EBITDA |
22.41B
est: 30.48B (-26.5%)
|
35.77B
est: 16.23B (+120.5%)
|
30.77B
est: 67.75B (-54.6%)
|
51.78B
est: 88.20B (-41.3%)
|
27.35B
est: 35.45B (-22.8%)
|
41.08B
est: 174.10M (+23,496.2%)
|
71.65B
est: 33.11B (+116.4%)
|
54.46B
est: 17.63B (+208.9%)
|
73.61B
73.61B – 73.61B
+317.6% YoY
|
95.82B
95.82B – 95.82B
+30.2% YoY
|
38.51B
38.51B – 38.51B
-59.8% YoY
|
| EBIT |
15.40B
est: 11.33B (+35.9%)
|
25.72B
est: 6.03B (+326.3%)
|
16.85B
est: 25.20B (-33.1%)
|
31.37B
est: 32.80B (-4.4%)
|
357.31M
est: 13.18B (-97.3%)
|
12.69B
est: 64.75M (+19,498.6%)
|
43.64B
est: 14.68B (+197.3%)
|
26.98B
est: 7.82B (+245.3%)
|
32.63B
32.63B – 32.63B
+317.6% YoY
|
42.48B
42.48B – 42.48B
+30.2% YoY
|
17.07B
17.07B – 17.07B
-59.8% YoY
|
| Net Income |
8.00B
est: 12.29B (-34.9%)
|
15.36B
est: 21.09B (-27.2%)
|
3.84B
est: 25.84B (-85.1%)
|
9.50B
|
-6.44B
est: -37.29B (+82.7%)
|
14.13B
|
16.46B
est: 12.35B (+33.2%)
|
29.21B
est: 21.20B (+37.8%)
|
25.97B
25.97B – 25.97B
+22.5% YoY
|
—
— – —
-100.0% YoY
|
-37.48B
-37.48B – -37.48B
|
| SGA |
9.05B
est: 23.76B (-61.9%)
|
14.50B
est: 12.65B (+14.6%)
|
19.12B
est: 52.83B (-63.8%)
|
20.55B
est: 68.77B (-70.1%)
|
16.86B
est: 27.64B (-39.0%)
|
27.31B
est: 135.75M (+20,014.4%)
|
24.96B
est: 24.95B (+0.0%)
|
30.12B
est: 13.28B (+126.7%)
|
55.47B
55.47B – 55.47B
+317.6% YoY
|
72.21B
72.21B – 72.21B
+30.2% YoY
|
29.02B
29.02B – 29.02B
-59.8% YoY
|
| EPS |
837.00
est: 1,286.00 (-34.9%)
|
1,607.00
est: 2,207.00 (-27.2%)
|
402.00
est: 2,704.00 (-85.1%)
|
994.21
|
-673.85
est: -3,903.00 (+82.7%)
|
1,479.00
|
1,720.22
est: 1,286.00 (+33.8%)
|
3,056.92
est: 2,207.00 (+38.5%)
|
2,704.00
2,704.00 – 2,704.00
+22.5% YoY
|
—
— – —
-100.0% YoY
|
-3,903.00
-3,903.00 – -3,903.00
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex KOSPI 226490.KS | 0.00% | 21.9K | 0.15% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Byung-Man Lee | CEO & Executive Director | 501M | male |
| Byungjoo Lee | CEO & Executive Director | 501M | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 044820.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
